Singapore, Aug. 24 -- Novotech, a leading global biotech CRO and full-service clinical research organisation, has strengthened its established presence in Japan with the opening of a new office in Tokyo. The investment builds on Novotech's existing operations and clinical trial activity in Japan and further enhances its ability to support Japanese biopharma companies as they advance programs regionally and across key international markets.

Japan is one of the world's largest and most advanced pharmaceutical markets, supported by a sophisticated research base and a rapidly evolving biotech sector. As more Japanese biopharma companies look to expand beyond domestic development and bring novel therapies to global markets, Novotech's expande...